Multicenter open-label study to evaluate efficacy of gadobutrolenhanced cardiac magnetic resonance imaging (CMRI) for detection of significant coronary artery disease (CAD) in subjects with known or suspected CAD by a blinded image analysis

Multicenter open-label study to evaluate efficacy of gadobutrolenhanced cardiac magnetic resonance imaging (CMRI) for detection of significant coronary artery disease (CAD) in subjects with known or suspected CAD by a blinded image analysis

Brief description of study

The primary efficacy objectives of this study are to demonstrate that sensitivity and specificity of gadobutrol-enhanced CMRI exceed prespecified minimum performance thresholds (MPT) of 60% and 55%, respectively and to show superior sensitivity over unenhanced wall motion CMRI at vasodilator rest/stress for the detection of significant coronary artery disease (CAD) in subjects with suspected or known CAD. The study is comparing the diagnostic ability of stress cardiac MRI (CMR) using this contrast agent as compared to coronary angiogram and gated SPECT.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Coronary heart disease,Coronary heart disease,coronary heart disease
  • Age: Between 1 Years - 99 Years
  • Gender: All


Updated on 03 Aug 2022. Study ID: 818179

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center